Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine

The article summarises materials on the certification of the industry reference standard of Schigella sonnei polysaccharide dysentery vaccine (commercial name — Schigellvac). The industry reference standard is used to assess the consistency of the vaccine «Specific activity» testing by passive hemag...

Full description

Bibliographic Details
Main Authors: V. A. Volkov, M. V. Abramtseva, T. I. Nemirovskaya, V. P. Kovtun, O. V. Fadeykina, R. A. Volkova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-12-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/198
_version_ 1797244502141829120
author V. A. Volkov
M. V. Abramtseva
T. I. Nemirovskaya
V. P. Kovtun
O. V. Fadeykina
R. A. Volkova
author_facet V. A. Volkov
M. V. Abramtseva
T. I. Nemirovskaya
V. P. Kovtun
O. V. Fadeykina
R. A. Volkova
author_sort V. A. Volkov
collection DOAJ
description The article summarises materials on the certification of the industry reference standard of Schigella sonnei polysaccharide dysentery vaccine (commercial name — Schigellvac). The industry reference standard is used to assess the consistency of the vaccine «Specific activity» testing by passive hemagglutination inhibition assay. A certification programme for the industry reference standard was developed. Samples of the candidate vaccine were tested in terms of the following quality characteristics: «Appearance», «Identification», «Extractable Volume». The test results confirmed that the samples comply with the current requirements of the manufacturer’s product specification file for Schigellvac vaccine. It was determined that the certification parameter — the polysaccharide dilution ratio which results in inhibition of passive hemagglutination in a homologous system — has to fall in the range from 1:128 to 1:512. The following set of standard documents accompanying a scientific/technological product was approved for the industry reference standard No. 42-28-386-2017: passport, patient information leaflet, mockup labels for primary and secondary packaging.
first_indexed 2024-03-08T21:44:17Z
format Article
id doaj.art-a6af1d41a6834aa093e45404a9df1756
institution Directory Open Access Journal
issn 2221-996X
2619-1156
language Russian
last_indexed 2024-04-24T19:12:01Z
publishDate 2018-12-01
publisher Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Биопрепараты: Профилактика, диагностика, лечение
spelling doaj.art-a6af1d41a6834aa093e45404a9df17562024-03-26T09:10:52ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562018-12-0118425726110.30895/2221-996X-2018-18-4-257-261150Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac VaccineV. A. Volkov0M. V. Abramtseva1T. I. Nemirovskaya2V. P. Kovtun3O. V. Fadeykina4R. A. Volkova5Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsThe article summarises materials on the certification of the industry reference standard of Schigella sonnei polysaccharide dysentery vaccine (commercial name — Schigellvac). The industry reference standard is used to assess the consistency of the vaccine «Specific activity» testing by passive hemagglutination inhibition assay. A certification programme for the industry reference standard was developed. Samples of the candidate vaccine were tested in terms of the following quality characteristics: «Appearance», «Identification», «Extractable Volume». The test results confirmed that the samples comply with the current requirements of the manufacturer’s product specification file for Schigellvac vaccine. It was determined that the certification parameter — the polysaccharide dilution ratio which results in inhibition of passive hemagglutination in a homologous system — has to fall in the range from 1:128 to 1:512. The following set of standard documents accompanying a scientific/technological product was approved for the industry reference standard No. 42-28-386-2017: passport, patient information leaflet, mockup labels for primary and secondary packaging.https://www.biopreparations.ru/jour/article/view/198industry reference standardschigellvacschigella sonnei polysaccharide dysentery vaccinequality characteristicsspecific activityshigellashigellosispassive hemagglutination inhibition assay
spellingShingle V. A. Volkov
M. V. Abramtseva
T. I. Nemirovskaya
V. P. Kovtun
O. V. Fadeykina
R. A. Volkova
Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
Биопрепараты: Профилактика, диагностика, лечение
industry reference standard
schigellvac
schigella sonnei polysaccharide dysentery vaccine
quality characteristics
specific activity
shigella
shigellosis
passive hemagglutination inhibition assay
title Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
title_full Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
title_fullStr Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
title_full_unstemmed Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
title_short Certification of a New Batch of the Industry Reference Standard of Polysaccharide Content in Schigellvac Vaccine
title_sort certification of a new batch of the industry reference standard of polysaccharide content in schigellvac vaccine
topic industry reference standard
schigellvac
schigella sonnei polysaccharide dysentery vaccine
quality characteristics
specific activity
shigella
shigellosis
passive hemagglutination inhibition assay
url https://www.biopreparations.ru/jour/article/view/198
work_keys_str_mv AT vavolkov certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine
AT mvabramtseva certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine
AT tinemirovskaya certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine
AT vpkovtun certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine
AT ovfadeykina certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine
AT ravolkova certificationofanewbatchoftheindustryreferencestandardofpolysaccharidecontentinschigellvacvaccine